RxDoctor Payments Data

Jason Ice, DO

Internal Medicine · Parma, OHNPI 1467951863

Payments from drug & device makers

$11,919in general payments, 2019–2025

Across 773 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Pfizer$804
  • Biohaven Pharmaceutical Holding Company Ltd.$754
  • AstraZeneca$687
  • Lilly USA, LLC$656
  • plus $5K from 36 others

What the payments were for

  • Food & beverage$11,85699%
  • Education$631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,919 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$177,218
Medicare patients
499
Services billed
2,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin115$107,244
OzempicSemaglutide84$87,075
EliquisApixaban66$66,995
Trelegy ElliptaFluticasone/Umeclidin/Vilanter77$66,177
XareltoRivaroxaban49$53,023
TrulicityDulaglutide47$42,496
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$16,762
Tresiba Flextouch U-100Insulin Degludec29$16,448
JanuviaSitagliptin Phosphate11$16,429
Repatha SureclickEvolocumab21$16,368
FarxigaDapagliflozin Propanediol11$14,986
TradjentaLinagliptin17$13,579
MyrbetriqMirabegron16$13,045
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$11,471
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$10,886

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$412$120,823132 claims
Novo NordiskOzempic$1,256$87,07584 claims
PfizerEliquis$804$66,99566 claims
GSKTrelegy Ellipta$651$66,17777 claims
Johnson & JohnsonXarelto$611$53,02349 claims
Lilly USA, LLCTrulicity$656$42,49647 claims
AstraZenecaBreztri Aerosphere, Farxiga$687$31,74838 claims
MerckJanuvia, Janumet$184$22,51023 claims
Astellas Pharma US IncMyrbetriq$61$13,04516 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$202$10,71814 claims
AbbVieSynthroid$2,450$4,15180 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Parma

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →